-
Omeicos raises €17M to run phase 2 atrial fibrillation trial
fiercebiotech
November 05, 2018
Omeicos Therapeutics has raised €17 million ($19 million) to develop an atrial fibrillation candidate. The Forbion-led series C round sets...
-
AI drug miner XtalPi raises another $46M in series B add-on
fiercebiotech
November 02, 2018
Chinese AI drug discovery startup XtalPi has raised another $46 million this year, in an extension of its venture capital round, to finance expansion of its computerized pharmaceutical research platform.
-
Telehealth firm 98point6 nets $50M in round led by Goldman Sachs
fiercebiotech
November 02, 2018
98point6, a digital health company that makes primary care doctors available to patients over cellphone messages, raised $50 million in a new financing round led by Goldman Sachs.
-
F-Prime, Atlas lead cancer startup Akrevia to $30M A round
fiercebiotech
September 28, 2018
Akrevia Therapeutics has raised a $30 million series A round led by F-Prime Capital Partners and Atlas Venture.
-
Roche-backed Minoryx raises €21M to expand CNS R&D
fiercebiotech
September 27, 2018
Minoryx has raised €21.3 million in series B funding. The round sets Minoryx up to expand clinical development of a neurodegenerative disease drug that has attracted the interest of organizations including Roche Venture Fund.
-
Chinese biotech Harbour lands $85M to run cancer trials
fiercebiotech
August 28, 2018
Shanghai-based biotech Harbour BioMed has raised $85 million (€73 million).